Your browser doesn't support javascript.
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure.
Michalick, Laura; Weidenfeld, Sarah; Grimmer, Benjamin; Fatykhova, Diana; Solymosi, Philip Daniel; Behrens, Felix; Dohmen, Melanie; Brack, Markus C; Schulz, Sabrina; Thomasch, Elisa; Simmons, Szandor; Müller-Redetzky, Holger; Suttorp, Norbert; Kurth, Florian; Neudecker, Jens; Toennies, Mario; Bauer, Torsten T; Eggeling, Stephan; Corman, Victor Max; Hocke, Andreas C; Witzenrath, Martin; Hippenstiel, Stefan; Kuebler, Wolfgang M.
  • Michalick L; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Weidenfeld S; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Grimmer B; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Fatykhova D; Dept of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Solymosi PD; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Behrens F; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Dohmen M; Berlin Institute of Health (BIH), Berlin, Germany.
  • Brack MC; Dept of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Schulz S; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Thomasch E; Dept of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Simmons S; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Müller-Redetzky H; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Suttorp N; Institute of Physiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Kurth F; Dept of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Neudecker J; Dept of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Toennies M; German Center for Lung Research (DZL), Germany.
  • Bauer TT; Dept of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Eggeling S; Dept of General, Visceral, Vascular and Thoracic Surgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Corman VM; Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany.
  • Hocke AC; Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany.
  • Witzenrath M; Vivantes Netzwerk für Gesundheit, Klinikum Neukölln, Klinik für Thoraxchirurgie, Berlin, Germany.
  • Hippenstiel S; Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
  • Kuebler WM; German Centre for Infection Research (DZIF), Germany.
Eur Respir J ; 57(3)2021 03.
Article in English | MEDLINE | ID: covidwho-914005

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma / Capillary Permeability / Electric Impedance / Endothelial Cells / Endothelium / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.02384-2020

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasma / Capillary Permeability / Electric Impedance / Endothelial Cells / Endothelium / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: 13993003.02384-2020